conventional doses of warfarin to prevent recurrent venous thromboembolism
September 2003
Experts will be sticking with conventional doses of warfarin to prevent recurrent venous thromboembolism.
For a while, it looked like the trend was going towards "low-intensity warfarin" for long-term prophylaxis.
It was hoped that titrating to a lower INR of 1.5 to 2.0 would be as effective and cause less bleeding than the usual INR target of 2.0 to 3.0.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote